Q3 2022 Holdings
Filed 2022-11-08 | 26 holdings | $63.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $27.0M | 8,980,909 | 42.8% |
| Arcus BioSciences, Inc.(RCUS) | COM | 03969F109 | $22.8M | 869,790 | 36.0% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $7.4M | 526,329 | 11.8% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $3.8M | 210,000 | 6.0% |
| Argenx SE(ARGX) | COM | 04016X101 | $2.0M | 5,529 | 3.1% |
| Alpine Immune Sciences, Inc.(NVLSEUR) | COM | 02083G100 | $48.3K | 6,708,288 | 0.1% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $39.5K | 1,824,583 | 0.1% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $24.8K | 130,138 | 0.0% |
| Prometheus Biosciences, Inc. | COM | 74349U108 | $14.8K | 250,000 | 0.0% |
| Albireo Pharma, Inc.(BDQM) | COM | 01345P106 | $12.1K | 623,342 | 0.0% |
| 10x Genomics, Inc.(TXG) | CL A COM | 88025U109 | $10.2K | 359,554 | 0.0% |
| Equillium Inc.(EQ) | COM | 29446K106 | $9.9K | 4,447,308 | 0.0% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $8.5K | 1,463,872 | 0.0% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $8.2K | 580,000 | 0.0% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $6.1K | 904,268 | 0.0% |
| Apexigen, Inc. | COM | 03759B102 | $5.1K | 1,894,551 | 0.0% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $4.9K | 4,958,143 | 0.0% |
| Horizon Therapeutics PLC | COM | G46188101 | $4.9K | 78,900 | 0.0% |
| Terns Pharmaceuticals, Inc.(TERN) | COM | 880881107 | $4.2K | 714,285 | 0.0% |
| Seagen Inc. | COM | 812578102 | $3.1K | 23,014 | 0.0% |
| Sema4 Holings Corp.(SMFRUSD) | COM CL A | 81663L101 | $3.0K | 3,418,929 | 0.0% |
| AtriCure Inc. | COM | 004963C20 | $1.8K | 46,259 | 0.0% |
| Scynexis Inc.(SCYX) | COM NEW | 811292200 | $1.3K | 555,555 | 0.0% |
| Owlet, Inc. | COM CL A | 69120X107 | $961 | 898,400 | 0.0% |
| Nautilus Biotechnology, Inc.(NAUT) | COM | 63909J108 | $636 | 300,000 | 0.0% |
| NeuBase Therapeutics, Inc. | COM | 64132K102 | $395 | 1,000,000 | 0.0% |